These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12419829)

  • 1. Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase. Recepteur d'origine nantais.
    Chen YQ; Zhou YQ; Fu LH; Wang D; Wang MH
    Carcinogenesis; 2002 Nov; 23(11):1811-9. PubMed ID: 12419829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo.
    Chen YQ; Zhou YQ; Fisher JH; Wang MH
    Oncogene; 2002 Sep; 21(41):6382-6. PubMed ID: 12214279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
    Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
    Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recepteur d'origine nantais contributes to the development of endometriosis via promoting epithelial-mesenchymal transition of a endometrial epithelial cells.
    Yu Q; Wang J; Li T; Guo X; Ding S; Che X; Zhu L; Peng Y; Xu X; Zou G; Zhang X
    J Cell Mol Med; 2021 Feb; 25(3):1601-1612. PubMed ID: 33410267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
    Wang MH; Wang D; Chen YQ
    Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
    Wang MH; Yao HP; Zhou YQ
    Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
    Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
    Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice.
    Dang TP; Eichenberger S; Gonzalez A; Olson S; Carbone DP
    Oncogene; 2003 Apr; 22(13):1988-97. PubMed ID: 12673204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
    Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential.
    Zhou YQ; He C; Chen YQ; Wang D; Wang MH
    Oncogene; 2003 Jan; 22(2):186-97. PubMed ID: 12527888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.
    Park JS; Choi HI; Kim DH; Kim CS; Bae EH; Ma SK; Kim SW
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.
    Feres KJ; Ischenko I; Hayman MJ
    Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel splicing variants of recepteur d'origine nantais (RON) tyrosine kinase involving exons 15-19 in lung cancer.
    Krishnaswamy S; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
    Lung Cancer; 2016 Feb; 92():41-6. PubMed ID: 26775595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder.
    Cheng HL; Liu HS; Lin YJ; Chen HH; Hsu PY; Chang TY; Ho CL; Tzai TS; Chow NH
    Br J Cancer; 2005 May; 92(10):1906-14. PubMed ID: 15870710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative genomic analyses of recepteur d'origine nantais and its prognostic value in cancer.
    Yu H; Yuan J; Xiao C; Qin Y
    Int J Mol Med; 2013 May; 31(5):1248-54. PubMed ID: 23483216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells.
    Xu XM; Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Nov; 23(52):8464-74. PubMed ID: 15378025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression.
    Chen YQ; Fisher JH; Wang MH
    J Immunol; 1998 Nov; 161(9):4950-9. PubMed ID: 9794431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer.
    Wu Z; Zhang Z; Ge X; Lin Y; Dai C; Chang J; Liu X; Geng R; Wang C; Chen H; Sun M; Guo W; Li J
    Oncotarget; 2015 Dec; 6(38):40519-34. PubMed ID: 26528757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities.
    Wang MH; Zhou YQ; Chen YQ
    Scand J Immunol; 2002 Dec; 56(6):545-53. PubMed ID: 12472665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of transplacentally induced mouse lung tumors.
    Miller MS; Leone-Kabler S; Rollins LA; Wessner LL; Fan M; Schaeffer DO; McEntee MF; O'Sullivan MG
    Exp Lung Res; 1998; 24(4):557-77. PubMed ID: 9659583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.